Integration of an EEG biomarker with a clinician's ADHD evaluation

Brain and Behavior

Volumn 5, Issue 4, 2015, Pages 1-17

  Snyder, Steven M ^a,b   Rugino, Thomas A ^c,d   Hornig, Mady ^e   Stein, Mark A ^f,g  

^a NEBA Health   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c Children's Specialized Hospital   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e Mailman School of Public Health   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Attention deficit hyperactivity disorder; Biomarkers; Comorbidity; Electroencephalography; Multidisciplinary; Sensitivity; Specificity

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BETA RHYTHM; CHILD; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; FOURIER TRANSFORMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOCIAL STATUS; THETA RHYTHM; TRIPLE BLIND PROCEDURE; WECHSLER INTELLIGENCE SCALE; WIDE RANGE ACHIEVEMENT TEST; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; PROCEDURES; UNITED STATES;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84926518700     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.330     Document Type: Article

References (52)

1. AACAP. 2007. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 46:894-921.
2. AAP. 2011. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128: 1-16.
3. Agresti, A., and B. A. Coull. 1998. Approximate is better than "exact" for interval estimation of binomial proportions. Am. Stat. 52:119-126.
4. APA. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th edn - text revision: DSM-IV-TR. American Psychiatric Association, Arlington, VA.
5. APA. 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American Psychiatric Association, Washington, DC.
6. Arns, M., C. K. Conners, and H. C. Kraemer. 2013. A decade of EEG theta/beta research in ADHD: a meta-analysis. J. Atten. Disord. 17:374-383.
7. Barry, R. J., A. R. Clarke, and S. J. Johnstone. 2003. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin. Neurophysiol. 114:171-183.
8. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 57:289-300.
9. Brown, B. W., and K. Russell. 1997. Methods of correcting for multiple testing: operating characteristics. Stat. Med. 16:2511-2528.
10. Bruchmuller, K., J. Margraf, and S. Schneider. 2012. Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. J. Consult. Clin. Psychol. 80:128-138.
11. Bush, G. 2008. Neuroimaging of attention deficit hyperactivity disorder: can new imaging findings be integrated in clinical practice? Child. Adolesc. Psychiatr. Clin. N. Am. 17:385-404.
12. Bush, G., E. M. Valera, and L. J. Seidman. 2005. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry 57:1273-1284.
13. Cantwell, D. P. 1996. Attention deficit disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry 35:978-987.
14. Cantwell, D. P., and L. Baker. 1987. Differential diagnosis of hyperactivity. J. Dev. Behav. Pediatr. 8:159-170.
15. CDC. 2014. Attention-Deficit/Hyperactivity Disorder (ADHD) Data & Statistics. http://www.cdc.gov/ncbddd/adhd/data.html, 2014.
16. Chilakamarri, J. K., M. M. Filkowski, and S. N. Ghaemi. 2011. Misdiagnosis of bipolar disorder in children and adolescents: a comparison with ADHD and major depressive disorder. Ann. Clin. Psychiatry 23:25-29.
17. Chou, R., L. H. Huffman, R. Fu, A. K. Smits, P. T. Korthuis, and US Preventive Services Task Force. 2005. Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 143:55-73.
18. Clarke, A. R., R. J. Barry, D. Bond, R. McCarthy, and M. Selikowitz. 2002a. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology 164:277-284.
19. Clarke, A. R., R. J. Barry, R. McCarthy, and M. Selikowitz. 2002b. EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder. Clin. Neurophysiol. 113:194-205.
20. Clarke, A. R., R. J. Barry, R. McCarthy, M. Selikowitz, and R. J. Croft. 2002c. EEG differences between good and poor responders to methylphenidate in boys with the inattentive type of attention-deficit/hyperactivity disorder. Clin. Neurophysiol. 113:1191-1198.
21. Clarke, A. R., R. J. Barry, R. McCarthy, M. Selikowitz, C. R. Brown, and R. J. Croft. 2003. Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive type. Int. J. Psychophysiol. 47:129-137.
22. Cortese, S. 2012. The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): what every clinician should know. Eur. J. Paediatr. Neurol. 16:422-433.
23. Daley, K. C. 2004. Update on attention-deficit/hyperactivity disorder. Curr. Opin. Pediatr. 16:217-226.
24. Dickstein, S. G., K. Bannon, F. X. Castellanos, and M. P. Milham. 2006. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J. Child Psychol. Psychiatry 47:1051-1062.
25. Dupuy, F. E., A. R. Clarke, R. J. Barry, R. McCarthy, and M. Selikowitz. 2011. Girls with attention-deficit/hyperactivity disorder: EEG differences between DSM-IV types. Clin. EEG Neurosci. 42:1-5.
26. Dupuy, F. E., R. J. Barry, A. R. Clarke, R. McCarthy, and M. Selikowitz. 2013. Sex differences between the combined and inattentive types of attention-deficit/hyperactivity disorder: an EEG perspective. Int. J. Psychophysiol. 89:320-327.
27. Elder, T. E. 2010. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J. Health Econ. 29:641-656.
28. FDA. 2013. De novo classification request for neuropsychiatric EEG-based assessment aid for ADHD (NEBA) system. K112711, July 15, 2013.
29. Insel, T., B. Cuthbert, M. Garvey, R. Heinssen, D. S. Pine, K. Quinn, et al. 2010. Research domain criteria (RDoc): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167:748-751.
30. Liechti, M. D., L. Valko, U. C. Muller, M. Dohnert, R. Drechsler, H. C. Steinhausen, et al. 2013. Diagnostic value of resting electroencephalogram in attention-deficit/hyperactivity disorder across the lifespan. Brain Topogr. 26:135-151.
31. Loo, S. K., A. Cho, T. S. Hale, J. McGough, J. McCracken, and S. L. Smalley. 2013. Characterization of the theta to beta ratio in ADHD: identifying potential sources of heterogeneity. J. Atten. Disord. 17:384-392.
32. Lou, H. C., and L. Hendrickson. 1989. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch. Neurol. 46:48-52.
33. Lou, H. C., L. Hendrickson, and P. Bruhn. 1984. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch. Neurol. 41:825-829.
34. Mirsky, A. F., and C. C. Duncan. 2001. A nosology of disorders of attention. Ann. N. Y. Acad. Sci. 931:17-32.
35. Monastra, V. J. 2008. Quantitative electroencephalography and attention-deficit/hyperactivity disorder: implications for clinical practice. Curr. Psychiatry. Rep. 10:432-438.
36. Monastra, V. J., J. F. Lubar, and M. Linden. 2001. The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: reliability and validity studies. Neuropsychology 15:136-144.
37. Morrow, R. L., E. J. Garland, J. M. Wright, M. Maclure, S. Taylor, and C. R. Dormuth. 2012. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ 184:755-762.
38. Nigg, J. T., E. G. Willcutt, A. E. Doyle, and E. J. S. Sonuga-Barke. 2004. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol. Psychiatry 57:1224-1230.
39. Nuwer, M. 1997. Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology 49:277-292.
40. Pearl, P. L., R. E. Weiss, and M. A. Stein. 2001. Medical mimics. Medical and neurological conditions simulating ADHD. Ann. N. Y. Acad. Sci. 931:97-112.
41. Pearl, P. L., R. E. Weiss, and M. A. Stein. 2015. Mimics of ADHD: medical and neurological conditions. Pp. 97-112. in L. A. Adler, T. J. Spencer and T. E. Wilens, eds. Attention Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press, Cambridge, UK.
42. Polanczyk, G., and P. Jensen. 2008. Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update. Child Adolesc. Psychiatr. Clin. N. Am. 17:245-260.
43. Rohde, L. A., J. Biederman, E. A. Busnello, H. Zimmermann, M. Schmitz, S. Martins, et al. 1999. ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J. Am. Acad. Child Adolesc. Psychiatry 38:716-722.
44. Rubia, K., R. Halari, A. Cubillo, A. B. Smith, A. M. Mohammad, M. Brammer, et al. 2011a. Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naive boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology 36:1575-1586.
45. Rubia, K., R. Halari, A. M. Mohammad, E. Taylor, and M. Brammer. 2011b. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder. Biol. Psychiatry 70:255-262.
46. Snyder, S. M., and J. R. Hall. 2006. A meta-analysis of quantitative electroencephalographic power associated with attention-deficit hyperactivity disorder. J. Clin. Neurophysiol. 23:441-456.
47. Snyder, S. M., H. Quintana, S. Sexson, P. Knott, A. F. M. Haque, and D. A. Reynolds. 2008. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res. 159:346-358.
48. Sowell, E. R., P. M. Thompson, S. E. Welcome, A. L. Henkenius, A. W. Toga, and B. S. Peterson. 2003. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362:1699-1707.
49. Thompson, W., and J. Hickey. 2005. Society in Focus. Pearson, Boston, MA.
50. Visser, S. N., M. L. Danielson, R. H. Bitsko, J. R. Holbrook, M. D. Kogan, R. M. Ghandour, et al. 2014. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J. Am. Acad. Child Adolesc. Psychiatry 53:34-46. e2.
51. Zametkin, A. J., and M. Ernst. 1999. Problems in the management of attention-deficit-hyperactivity disorder. N. Engl. J. Med. 340:40-46.
52. Zametkin, A. J., T. E. Nordahl, M. Gross, A. C. King, W. E. Semple, J. Rumsey, et al. 1990. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Engl. J. Med. 323:1361-1366.